Biology
Mechanisms of Antibiotic Resistance in Bacterial Biofilms
Quick fact
A single biofilm can contain billions of bacteria, and they are so resilient that they can withstand antibiotic concentrations 10–1000 times higher than those needed to kill free-floating bacteria of the same species.
Why this is interesting
We often think of bacteria as solitary swimmers, but in your body they prefer to build sticky cities that are up to 1,000 times more resistant to antibiotics. Why do these microscopic metropolises shrug off drugs that kill their free-floating cousins?
Read the full explanation
Understanding Mechanisms of Antibiotic Resistance in Bacterial Biofilms
Imagine bacteria as tiny single-celled organisms. When they land on a surface—like a medical implant or a lung airway—they often switch to a communal lifestyle. Instead of swimming freely, they attach, multiply, and produce a slimy, glue-like substance called the extracellular polymeric substance (EPS). This matrix, made of sugars, proteins, and DNA, forms a protective fortress. Inside this fortress, the bacteria are not just passively shielded; they actively change their behavior and physiology. The result is that antibiotics, which are designed to interfere with bacterial growth or kill them outright, become far less effective. This is not just a matter of the matrix physically blocking the drug; it's a combination of several coordinated defenses that together create what we call biofilm tolerance—a state of high resistance that is not inherited but rather a collective, community-level phenomenon.
A deeper explanation
The resistance of biofilms arises from four main complementary mechanisms. 1. Physical barrier and limited penetration: The EPS matrix acts as a diffusion barrier. Some antibiotics, especially positively charged ones like aminoglycosides, bind to the negatively charged matrix components and are neutralized before they reach deeper bacteria. Also, the matrix can slow diffusion, delaying the drug's action. 2. Persister cells: Inside the biofilm, a subpopulation of cells enters a dormant, slow-growing state. These persisters are not genetically mutated; they merely switch off their metabolic machinery. Since most antibiotics target active processes (like cell wall synthesis or protein production), they cannot kill these dormant cells. When the antibiotic is removed, persisters can repopulate the biofilm, causing recurring infections. 3. Nutrient and oxygen gradients: As the biofilm grows, bacteria at the surface consume oxygen and nutrients, creating gradients. Deep layers become oxygen-depleted and nutrient-poor, forcing bacteria to grow very slowly or enter a stationary phase. Slow growth reduces the efficacy of antibiotics that require active growth. 4. Adaptive stress responses and efflux pumps: The biofilm environment triggers the expression of stress-response genes, including those encoding efflux pumps that actively pump antibiotics out of the cell. Additionally, the SOS response (a DNA repair system) is activated, enhancing mutation rates and horizontal gene transfer, which can spread actual resistance genes between bacteria. These mechanisms act synergistically. For example, the matrix slows drug penetration, allowing the deeper bacteria to activate stress responses and become persister cells. The combination of tolerance (via persistence and slow growth) and resistance (via genetic mutations and efflux pumps) makes biofilms extremely hard to eradicate. This is why chronic biofilm infections—such as those in the lungs of cystic fibrosis patients or on indwelling catheters—often recur even after aggressive antibiotic therapy, and why new strategies, like disrupting the matrix or targeting persister cells, are being developed.